UTC Investment

UTC Investment, established in 1988, specializes in private equity investments with a strong focus on the buyout sector. The firm has built a reputation as a leading global investment entity, demonstrating a successful track record in managing diverse human resources. In addition to its core private equity activities, UTC Investment operates the UTC New Deal Venture Fund, which is a venture capital fund based in Seoul, South Korea. This fund further enhances UTC Investment's commitment to fostering innovation and supporting new ventures in the region.

Seayeon Kim

CEO

18 past transactions

Rznomics

Series C in 2022
This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.

Creatz

Series A in 2021
Creatz is a sports consulting online platform based on artificially generated data.

PDC*line Pharma

Series B in 2021
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

Nexel

Series B in 2021
Nexel is a biotechnology research firm focused on advancing drug discovery and biotherapeutics. The company specializes in developing high-quality induced pluripotent stem cell (iPSC) products using embryonic stem cell technology. By providing innovative solutions and drug discovery pipelines, Nexel aims to address unmet medical needs and enhance therapeutic options for various diseases.

Localstitch

Series A in 2021
Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.

Seculetter

Series B in 2020
SecuLetter Co.,Ltd. develops, manufactures, and markets cyber security appliances to detect unknown attacks with hybrid approaches. Its products include SecuLetter Email (SLE), a threat analysis protection solution for email that blocks cyber attacks which use malicious code; and SecuLetter FileServer (SLF), a threat analysis protection solution for fileserver that blocks the attack via attachment which targets organization that shares files server for co-work. The company was founded in 2015 and is based in Seongnam-si, South Korea.

PDC*line Pharma

Series B in 2020
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

Localstitch

Seed Round in 2019
Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.

Logispot

Series B in 2019
LOGISPOT Co., Ltd. provides inland freight transportation services to companies ranging from large enterprises to small and medium enterprises (SMEs) in South Korea. The company was founded in 2016 and is based in Seoul, South Korea.

Oncorus

Series B in 2019
Oncorus, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative viral immunotherapies for cancer treatment. The company's lead candidate, ONCR-177, utilizes an oncolytic herpes simplex virus type 1 platform and is currently in Phase I clinical trials aimed at treating various cancers. In addition to ONCR-177, Oncorus is advancing the ONCR-GBM program for brain cancer and exploring synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has entered a collaboration with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 in combination with Merck’s immunotherapy. Founded in 2015 and headquartered in Cambridge, Massachusetts, Oncorus is committed to advancing cancer care and has pledged to support cancer research and healthcare initiatives in developing regions through corporate philanthropy.

I-ON Digital Corp

Venture Round in 2019
I-ON Digital Corp. engages in the development and supply of unstructured data management and digital marketing software and solutions in South Korea and Japan. It offers enterprise content management system and digital experience solutions, such as I-ON Content Server, I-ON Content Application Framework Engine, I-ON Deploy Server, I-ON Content Ecosystem, I-ON Digital Asset Management System, and I-ON Web Analytics Server; and sports and IT convergence service and solutions, which include Ticket Advanced Marketing Management, a mobile business to business to consumer platform that integrates and manages the professional sports events, as well as VoiceBall, an amateur league umpire and data service. The company also provides software as a service solutions, which include GAIA, a distributed repository service; iDrive, an e-document management system; e.Form, a mobile contract platform; and Assist9, a mobile enterprise resource planning dashboard. In addition, it offers energy management solutions comprising Load Aggregator’s Management System, a demand response management solution designed to manage and reduce electricity consumption. The company was formerly known as I-ON Communications Corp. I-ON Digital Corp. was founded in 1999 and is headquartered in Seoul, South Korea.

Woman’s Talk

Venture Round in 2017
Woman’s Talk is viewed by its users as a ‘friendly’ platform for the way in which it provides users with pricing and product related information. A key factor in the success of the business is the requirement for product brands to provide their most competitive price and product guarantee. Woman’s Talk in return provides a lower service fee compared to traditional distribution services whilst also providing the full marketing support required to promote the product.

VNPT EPay

Acquisition in 2016
VNPT Electronic Payment JSC provides electronic payment services. It offers payment solutions, such as card charging, SMS, and Megabank services; top-up services for recharging in games and phones; E-wallet services; and MegaCard.vn, an online service portal for supporting the gaming community. The company is based in Hanoi, Vietnam.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.